Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:08 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 566 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Vaginal Diseases Clear all

Conditions: Sexually Transmitted Infections, HIV Infections
Interventions: Not listed
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Vaginal Prolapse
Interventions: AMS Prolapse Product; Device
Lead sponsor: ASTORA Women's Health; Industry
Eligibility: 21 Years and older · Female only
Enrollment: 1,543 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Whitinsville, Massachusetts

Conditions: Cervical Cancer, Uterine Cancer, Vaginal Cancer, Vulvar Cancer, Bladder Cancer
Interventions: Image-Guided Brachytherapy; Device
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years to 100 Years · Female only
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Chlamydia Infections, Gonorrhea, Trichomonas Infections
Interventions: APTIMA® Trichomonas vaginalis & APTIMA® COMBO 2® Assays; Device
Lead sponsor: Gen-Probe, Incorporated; Industry
Eligibility: 16 Years and older · Female only
Enrollment: 1,336 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2013
U.S. locations: 14
States / cities: Birmingham, Alabama • San Diego, California • North Miami, Florida + 11 more

Conditions: Vaginal Prolapse
Interventions: Not listed
Lead sponsor: Larry Sirls; Other
Eligibility: Female only
Enrollment: 417 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Human Immunodeficiency Virus
Interventions: placebo ring, dapivirine ring; Combination Product
Lead sponsor: International Partnership for Microbicides, Inc.; Industry
Eligibility: 15 Years to 17 Years · Female only
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 11
States / cities: Birmingham, Alabama • Aurora, Colorado • Boston, Massachusetts + 3 more

Conditions: Pelvic Organ Prolapse
Interventions: Not listed
Lead sponsor: Atlantic Health System; Other
Eligibility: 18 Years and older · Female only
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Cancer
Interventions: ziv-aflibercept; Biological
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years to 120 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 1
States / cities: New York, New York

Conditions: Bacterial Vaginosis, Vulvovaginal Candidiasis, Trichomoniasis
Interventions: NAAT testing; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older · Female only
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Cervical Cancer, Endometrial Cancer, Radiation Toxicity, Vaginal Cancer
Interventions: survey administration, computer-assisted intervention, telephone-based intervention; Other · Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Stanford, California

Conditions: Ovarian Cancer, Ovarian Carcinoma, Endometrial Cancer, Uterine Cancer, Cervical Cancer, Vulvar Cancer, Gynecologic Cancer, Vaginal Cancer
Interventions: Belzutifan; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Breast Neoplasms
Interventions: Biospecimen Collection, Electronic Health Record Review, Questionnaire Administration; Procedure · Other
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Bacterial Vaginosis
Interventions: LC106, LC115, Placebo, Metronidazole Oral; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: HIV Infections
Interventions: Tenofovir disoproxil fumarate, Tenofovir gel; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 168 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 4
States / cities: Birmingham, Alabama • The Bronx, New York • Cleveland, Ohio + 1 more

Conditions: Mucosal Inflammation, Contraceptive; Complications, Intrauterine
Interventions: Copper IUD, Etonogestrel implant, Levonorgestrel IUS, DMPA Sub-cutaneous; Drug
Lead sponsor: Eastern Virginia Medical School; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Bacterial Vaginosis
Interventions: Low dose LACTIN-V applicator, Medium dose LACTIN-V applicator, High dose LACTIN-V applicator, Low dose Placebo applicator, Medium dose Placebo, High dose Placebo applicator; Biological · Other
Lead sponsor: Osel, Inc.; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Vaginal Atrophy, Genitourinary System; Disorder, Female, Vaginal Abnormality, Sexual Dysfunction, Sexual Problem
Interventions: Viveve®; Device
Lead sponsor: W. Grant Stevens, MD; Other
Eligibility: 18 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Marina del Rey, California

Conditions: Infertility
Interventions: INVOcell Culture Device, IVF Incubation; Device
Lead sponsor: Invaron Pharmaceuticals Inc.; Industry
Eligibility: 18 Years to 38 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Beford, Texas

Conditions: Irritable Bowel Syndrome, Vaginal Health
Interventions: Vaginal Probiotic; Dietary Supplement
Lead sponsor: Rael; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Gender Identity Disorder of Adult, Voiding Disorders, Sexual Dysfunction
Interventions: Focus group interviews, Questionnaire packet; Other · Diagnostic Test
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Stress Urinary Incontinence (SUI)
Interventions: disposable, single-use pessary; Device
Lead sponsor: Procter and Gamble; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Chandler, Arizona

Conditions: Urinary Incontinence, Stress Urinary Incontinence
Interventions: Gynecare TVT-SECUR system; Device
Lead sponsor: Michigan Institution of Women's Health PC; Other
Eligibility: 21 Years to 89 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Dearborn, Michigan

Conditions: Sexual Dysfunctions, Psychological, Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Genital Neoplasms, Female
Interventions: GyneGals Support Group; Behavioral
Lead sponsor: Women's College Hospital; Other
Eligibility: 18 Years and older · Female only
Enrollment: 398 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Bacterial Vaginosis
Interventions: DARE-BV1; Drug
Lead sponsor: Daré Bioscience, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: San Antonio, Texas

Search by objective public record fields.

Sexually Transmitted Infections Among African American Women Who Have Sex With Women

Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products

Image-Guided Gynecologic Brachytherapy

Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays

Surgical Outcomes of Vaginal Prolapse Repair With Elevate

Study of Dapivirine Vaginal Ring (VR) in Adolescents

Evaluation of the Avaulta Procedure for the Correction of Pelvic Organ Prolapse - Results at 1 Year

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis

Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE Study

Vaginal lIve Biotherapeutic RANdomized Trial

Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women

Impact of Contraceptives on Cervico-Vaginal Mucosa

Safety Study of Lactobacillus Administered Vaginally to Healthy Women

A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment Outcomes

Vaginal Culture Using INVOcell Compared to Traditional IVF Incubation

A Single Group Study to Evaluate the Effects of a Vaginal Probiotic on Vaginal and Digestive Health

Transgender Post-reassignment Urogynecologic Measures and Perceptions

A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence (SUI)

TVT-SECUR as an Office-based Procedure

A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer

Pharmacokinetic Study of DARE-BV1